Monogram Orthopaedics Inc...

2.69
-0.10 (-3.58%)
At close: Mar 31, 2025, 12:14 PM

Company Description

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants.

The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.

Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.

The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017.

The company was incorporated in 2016 and is headquartered in Austin, Texas.

Monogram Orthopaedics Inc.
Monogram Orthopaedics Inc. logo
Country United States
IPO Date May 18, 2023
Industry Medical - Devices
Sector Healthcare
Employees 27
CEO Benjamin Sexson C.F.A.

Contact Details

Address:
3913 Todd Lane
Austin, Texas
United States
Website https://www.monogramorthopedics.com

Stock Details

Ticker Symbol MGRM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001769759
CUSIP Number 609786108
ISIN Number US6097861081
Employer ID 81-2349540
SIC Code 3841

Key Executives

Name Position
Benjamin Sexson C.F.A. Chairman of the Board, President & Chief Executive Officer
Dr. Kamran Shamaei Ph.D. Chief Technology Officer
Noel Knape CPA, M.B.A. Chief Financial Officer
Chris Tyson Executive Vice President - MZ North America
Dr. Douglas Unis Founder, Chief Medical Officer & Director

Latest SEC Filings

Date Type Title
Mar 17, 2025 8-K Current Report
Mar 13, 2025 8-K/A [Amend] Current Report
Mar 12, 2025 10-K Annual Report
Mar 12, 2025 8-K Current Report
Feb 25, 2025 8-K Current Report
Dec 26, 2024 8-K Current Report
Dec 18, 2024 8-K Current Report
Dec 02, 2024 8-K Current Report
Nov 26, 2024 4 Filing
Nov 14, 2024 10-Q Quarterly Report